Healthcare provider profile · identity verified

James M Webb, DO

Allopathic & Osteopathic Physicians|Family Medicine · GRESHAM, OR · NPI 1942266838

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show James M Webb, DO received $26.60 in general payments during 2025 across 1 reported records.

Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 249 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 14 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 60 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$26.60

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Lilly USA, LLC	Unresolved — no canonical attribution shown	$26.60	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Education	$26.60	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Payment records were found, but the reported records did not identify a specific associated product for this analysis.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	249	43
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	14	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	60	13

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	748	210
Lisinopril	Lisinopril	464	123
Metformin Hcl	Metformin Hcl	434	122
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	400	67
Amlodipine Besylate	Amlodipine Besylate	394	113
Omeprazole	Omeprazole	381	109
Tamsulosin Hcl	Tamsulosin Hcl	377	103
Losartan Potassium	Losartan Potassium	325	91
Metoprolol Succinate	Metoprolol Succinate	320	85
Levothyroxine Sodium	Levothyroxine Sodium	304	79
Gabapentin	Gabapentin	300	64
Trazodone Hcl	Trazodone Hcl	268	68
Jardiance	Empagliflozin	249	43
Eliquis	Apixaban	238	52
Oxycodone Hcl	Oxycodone Hcl	230	31
Hydrochlorothiazide	Hydrochlorothiazide	220	76
Potassium Chloride	Potassium Chloride	208	61
Albuterol Sulfate Hfa	Albuterol Sulfate	206	76
Furosemide	Furosemide	204	52
Duloxetine Hcl	Duloxetine Hcl	152	38
Allopurinol	Allopurinol	151	35
Rosuvastatin Calcium	Rosuvastatin Calcium	147	43
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	133	13
Pravastatin Sodium	Pravastatin Sodium	132	37
Mirtazapine	Mirtazapine	131	17
Carvedilol	Carvedilol	123	38
Clopidogrel	Clopidogrel Bisulfate	121	25
Finasteride	Finasteride	119	36
Simvastatin	Simvastatin	119	30
Pantoprazole Sodium	Pantoprazole Sodium	115	38
Montelukast Sodium	Montelukast Sodium	113	32
Sertraline Hcl	Sertraline Hcl	106	26
Fluticasone Propionate	Fluticasone Propionate	100	40
Prednisone	Prednisone	100	51
Donepezil Hcl	Donepezil Hcl	91	22
Tizanidine Hcl	Tizanidine Hcl	84	23
Glipizide Er	Glipizide	83	24
Alendronate Sodium	Alendronate Sodium	82	32
Doxycycline Hyclate	Doxycycline Hyclate	77	46
Lovastatin	Lovastatin	75	18
Meloxicam	Meloxicam	75	35
Pioglitazone Hcl	Pioglitazone Hcl	73	19
Tramadol Hcl	Tramadol Hcl	73	24
Liothyronine Sodium	Liothyronine Sodium	70	20
Azithromycin	Azithromycin	69	48
Glipizide	Glipizide	65	16
Famotidine	Famotidine	64	23
Pregabalin	Pregabalin	64	16
Testosterone Cypionate	Testosterone Cypionate	64	15
Buspirone Hcl	Buspirone Hcl	63	16
Telmisartan	Telmisartan	63	18
Hydroxyzine Hcl	Hydroxyzine Hcl	62	21
Methylprednisolone	Methylprednisolone	61	52
Metoprolol Tartrate	Metoprolol Tartrate	61	29
Triamcinolone Acetonide	Triamcinolone Acetonide	61	34
Trulicity	Dulaglutide	60	13
Citalopram Hbr	Citalopram Hydrobromide	59	15
Paroxetine Hcl	Paroxetine Hcl	59	14
Zolpidem Tartrate	Zolpidem Tartrate	59	16
Atenolol	Atenolol	53	15
Baclofen	Baclofen	53	13
Topiramate	Topiramate	53	suppressed
Nystatin	Nystatin	52	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	12
Spironolactone	Spironolactone	50	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Propranolol Hcl	Propranolol Hcl	49	12
Memantine Hcl	Memantine Hcl	48	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	12
Venlafaxine Hcl Er	Venlafaxine Hcl	47	12
Glimepiride	Glimepiride	45	14
Testosterone	Testosterone	45	suppressed
Hydrocortisone	Hydrocortisone	44	19
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	11
Ozempic	Semaglutide	43	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	43	suppressed
Valsartan	Valsartan	42	11
Acetaminophen-Codeine	Acetaminophen With Codeine	41	suppressed
Acyclovir	Acyclovir	41	13
Quetiapine Fumarate	Quetiapine Fumarate	41	13
Oxybutynin Chloride	Oxybutynin Chloride	40	11
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Bupropion Xl	Bupropion Hcl	39	13
Chlorthalidone	Chlorthalidone	39	14
Divalproex Sodium	Divalproex Sodium	39	suppressed
Ondansetron Hcl	Ondansetron Hcl	39	21
Estradiol	Estradiol	37	16
Diazepam	Diazepam	36	16
Escitalopram Oxalate	Escitalopram Oxalate	36	suppressed
Methocarbamol	Methocarbamol	36	suppressed
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Mupirocin	Mupirocin	36	22
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	28
Warfarin Sodium	Warfarin Sodium	36	suppressed
Meclizine Hcl	Meclizine Hcl	35	14
Azelastine Hcl	Azelastine Hcl	34	15
Aripiprazole	Aripiprazole	33	suppressed
Ezetimibe	Ezetimibe	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Valacyclovir	Valacyclovir Hcl	33	15
Ondansetron Odt	Ondansetron	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	27	11
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Torsemide	Torsemide	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	15
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Cephalexin	Cephalexin	24	20
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	15
Dicyclomine Hcl	Dicyclomine Hcl	24	suppressed
Nateglinide	Nateglinide	24	suppressed
Raloxifene Hcl	Raloxifene Hcl	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	14
Metformin Hcl Er	Metformin Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ramipril	Ramipril	21	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Primidone	Primidone	20	suppressed
Risperidone	Risperidone	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Fluconazole	Fluconazole	19	12
Ipratropium Bromide	Ipratropium Bromide	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Terbinafine Hcl	Terbinafine Hcl	19	12
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Naproxen	Naproxen	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Cefuroxime	Cefuroxime Axetil	17	15
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Tadalafil	Tadalafil	17	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Farxiga	Dapagliflozin Propanediol	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Spiriva Handihaler	Tiotropium Bromide	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Insulin Lispro	Insulin Lispro	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Aranesp	Darbepoetin Alfa In Polysorbat	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Enbrel Sureclick	Etanercept	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Ramelteon	Ramelteon	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Amoxicillin	Amoxicillin	11	11
Folic Acid	Folic Acid	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Mydayis	Dextroamphetamine/Amphetamine	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$26.60 · 1 records	Lilly USA, LLC	—	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error